Characterization of Pseudomonas aeruginosa isolates from dogs and cats in Japan: Current status of antimicrobial resistance and prevailing resistance mechanisms

Microbiology and Immunology

Volumn 56, Issue 2, 2012, Pages 123-127

  Harada, Kazuki ^a   Arima, Sayuri ^a   Niina, Ayaka ^a   Kataoka, Yasushi ^a   Takahashi, Toshio ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

Antimicrobial resistance; Companion animals; Fluoroquinolone; Pseudomonas aeruginosa.

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM; BETA LACTAMASE; CATALASE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; ENROFLOXACIN; GENTAMICIN; IMIPENEM; ISOLEUCINE; ORBIFLOXACIN; OXIDOREDUCTASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN PARC; PROTEIN PARE; QUINOLONE DERIVATIVE; THREONINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CAT; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; ENZYME SYNTHESIS; GRAM STAINING; JAPAN; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NOTE; PSEUDOMONAS AERUGINOSA; SPECIES DIFFERENCE; UPREGULATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CAT DISEASES; CATS; DOG DISEASES; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; JAPAN; MICROBIAL SENSITIVITY TESTS; MUTATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

ANIMALIA; CANIS FAMILIARIS; PSEUDOMONAS AERUGINOSA;

EID: 84863230477     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00416.x     Document Type: Note

References (26)

1. Šeol B., Naglić T., Madić J., Bedeković M. (2002) In vitro antimicrobial susceptibility of 183 Pseudomonas aeruginosa strains isolated from dogs to selected antipseudomonal agents. J Vet Med B 49: 188-92.
2. Rorich P.J., Ling G.V., Ruby A.L., Jang S.S., Johnson D.L. (1983) In vitro susceptibilities of canine urinary bacteria to selected antimicrobial agents. J Am Vet Med Assoc 183: 863-7.
3. Lister P.D., Wolter D.J., Hanson N.D. (2009) Antibacterial-resistant Pseudomonas aeruginosa: Clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22: 582-610.
4. Teresa Tejedor M., Martín J.L., Navia M., Freixes J., Vila J. (2003) Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections. Vet Microbiol 94: 295-301.
5. Rubin J., Walker R.D., Blickenstaff K., Bodeis-Jones S., Zhao S. (2008) Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections. Vet Microbiol 131: 164-72.
6. De Vos D., Lim A. Jr, Pirnay J.P., Struelens M., Vandenvelde C., Duinslaeger L., Vanderkelen A., Cornelis P. (1997) Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectrations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL. J Clin Microbiol 35: 1295-9.
7. Clinical and Laboratory Standards Institute. (2009) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - eighth edition. CLSI document M07-A8. Wayne, PA
8. Clinical and Laboratory Standards Institute. (2008) Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard - third edition. CLSI document M31-A3. Wayne, PA
9. Clinical and Laboratory Standards Institute. (2010) Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20. Wayne, PA
10. Jiang X., Zhang Z., Li M., Zhou D., Ruan F., Lu Y. (2006) Detection of extended-spectrum β-lactamases in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 50: 2990-5.
11. El Amin N., Giske C.G., Jalal S., Keijser B., Kronvall G., Wretlind B. (2005) Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. APMIS 113: 187-96.
12. Rodríguez-Martínez J.M., Poirel L., Nordmann P. (2009) Extended-spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob Agents Chemother 53: 1766-71.
13. Mouneimné H., Robert J., Jarlier V., Cambau E. (1999) Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 43: 62-6.
14. Akasaka T., Tanaka M., Yamaguchi A., Sato K. (2001) Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother 45: 2263-8.
15. Sekiguchi J., Asagi T., Miyoshi-Akiyama T., Kasai A., Mizuguchi Y., Araake M., Fujino T., Kikuchi H., Sasaki S., Watari H., Kojima T., Miki H., Kanemitsu K., Kunishima H., Kikuchi Y., Kaku M., Yoshikura H., Kuratsuji T., Kirikae T. (2007) Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol 45: 979-89.
16. Martín Barrasa J.L., Lupiola Gómez P., González Lama Z., Tejedor Junco M.T. (2000) Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa. J Vet Med B 47: 191-6.
17. Masuda N., Sakagawa E., Ohya S., Gotoh N., Tsujimoto H., Nishino T. (2000) Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44: 3322-7.
18. Ozaki K., Inoue A., Atobe H., Takahashi E., Konishi S. (1990) Serotypes and antimicrobial susceptibility of Pseudomonas aeruginosa strains isolated from diseased dogs. Jpn J Vet Sci 52: 233-9.
19. Wildermuth B.E., Griffin C.E., Rosenkrantz W.S., Boord M.J. (2007) Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin. J Am Anim Hosp Assoc 43: 337-41.
20. Strateva T., Yordanov D. (2009) Pseudomonas aeruginosa- a phenomenon of bacterial resistance. J Med Microbiol 58: 1133-48.
21. Pasquali F., Manfreda G. (2007) Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa. Vet Microbiol 119: 304-10.
22. Uchida Y., Mochimaru T., Morokuma Y., Kiyosuke M., Fujise M., Eto F., Harada Y., Kadowaki M., Shimono N., Kang D. (2010) Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia. Int J Antimicrob Agent 35: 387-91.
23. Holm B., Petersson U., Mörner A., Bergström K., Franklin A., Greko C. (2002) Antimicrobial resistance in staphylococci from canine pyoderma: a prospective study of first-time and recurrent cases of pyoderma in Sweden. Vet Rec 151: 600-5.
24. Hagman R., Greko C. (2005) Antimicrobial resistance in Escherichia coli isolated from bitches with pyometra and from urine sample from other dogs. Vet Rec 157: 193-7.
25. Petersen A.D., Walker R.D., Bowman M.M., Schott H.C. II, Rosser E.J. Jr. (2002) Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997). J Am Anim Hosp Assoc 38: 407-13.
26. Werckenthin C., Alešík E., Grobbel M., Lubke-Becker A., Schwarz S., Wieler L.H., Wallmann J. (2007) Antimicrobial susceptibility of Pseudomonas aeruginosa from dogs and cats as well as Arcanobacterium pyogenes from cattle and swine as determined in the BfT-GermVet monitoring program 2004-2006. Berl Munch Tierärztl Wochenschr 120: 412-22.